STipe Therapeutics

📍 Denmark, Denmark🗓 Founded 2018👥 28 employees💰 Last funded Sep 2019
Biotechnology🌐 stipetherapeutics.com
Website LinkedIn
STipe Therapeutics is a privately held biotechnology company with a vision to become a leader in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The Company was spun out from Aarhus University, Denmark in 2018 and concluded a EUR 20 million a Series A financing in September 2019. JOB RECRUITMENT SCAM ALERT STipe Therapeutics is aware of a job recruitment scam involving fraudulent human resources recruiters contacting job seekers. The scam includes requesting personal information, promising or requesting money to purchase office equipment, and interacting and conducting false interviews via social media platforms. Please note STipe Therapeutics does not utilize social media platforms to conduct formal job interviews or extend employment offers with job seekers. We encourage job seekers to be aware of this scam and remain vigilant while searching for a job with STipe Therapeutics.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in STipe Therapeutics?
STipe Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did STipe Therapeutics last raise funding?
The most recent investment in STipe Therapeutics recorded on gritt.io was in September 2019.
When was STipe Therapeutics founded?
STipe Therapeutics was founded in 2018.
What industry is STipe Therapeutics in?
STipe Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is STipe Therapeutics based?
STipe Therapeutics is headquartered in Denmark, Denmark.